Clinical Trial Detail

NCT ID NCT03357757
Title Avelumab With Valproic Acid in Virus-associated Cancer (LATENT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors AHS Cancer Control Alberta
Indications

cervical squamous cell carcinoma

head and neck squamous cell carcinoma

nasopharynx carcinoma

penis squamous cell carcinoma

non-Hodgkin lymphoma

Hodgkin's lymphoma

squamous cell carcinoma

vulva squamous cell carcinoma

anal squamous cell carcinoma

Therapies

Avelumab + Valproic Acid

Age Groups: senior adult

Additional content available in CKB BOOST